+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Viral Vector"

Latin America Vaccine Market Report and Forecast 2025-2034 - Product Thumbnail Image

Latin America Vaccine Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 300 Pages
  • Latin America
From
Europe Bioreactors Market Outlook, 2030 - Product Thumbnail Image

Europe Bioreactors Market Outlook, 2030

  • Report
  • August 2025
  • 101 Pages
  • Europe
From
North America Bioreactors Market Outlook, 2030 - Product Thumbnail Image

North America Bioreactors Market Outlook, 2030

  • Report
  • August 2025
  • 90 Pages
  • North America
From
Middle East and Africa Bioreactors Market Outlook, 2030 - Product Thumbnail Image

Middle East and Africa Bioreactors Market Outlook, 2030

  • Report
  • August 2025
  • 80 Pages
  • Africa, Middle East
From
Asia-Pacific Bioreactors Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Bioreactors Market Outlook, 2030

  • Report
  • August 2025
  • 98 Pages
  • Asia Pacific
From
Asia-Pacific Cell Counting Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Cell Counting Market Outlook, 2030

  • Report
  • June 2025
  • 95 Pages
  • Asia Pacific
From
From
From
From
Loading Indicator

The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases. Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field. The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more